Biological fate and effects of propranolol in an experimental aquatic food chain

Science of the Total Environment

Volumn 532, Issue , 2015, Pages 31-39

  Ding, Jiannan ^a   Lu, Guanghua ^a   Li, Sheng ^a   Nie, Yang ^a   Liu, Jianchao ^a  

^a HOHAI UNIVERSITY   (China)

Author keywords

Algae; Biomarker; Crucian carp; Daphnia; Food chain transfer; Metabolism; Propranolol

Indexed keywords

BIOCHEMISTRY; BIOMARKERS; CHAINS; ENZYMES; GLUCOSE; METABOLISM; OXYGEN; PHYSIOLOGY; RISK ASSESSMENT;

BIOCHEMICAL PERTURBATIONS; CRUCIAN CARP; DAPHNIA; FOOD CHAIN; MULTIPLE BIOMARKERS; PROPRANOLOL; SCENEDESMUS OBLIQUUS; SUPER OXIDE DISMUTASE;

ALGAE;

7 BENZYLOXYRESORUFIN O DEALKYLASE; BIOLOGICAL MARKER; DIHYDROXYPROPRANOLOL GLUCURONIDE; ETHOXYRESORUFIN DEETHYLASE; HYDROXYPROPRANOLOL GLUCURONIDE; MALONALDEHYDE; MONOHYDROXYLATED PROPRANOLOL; N DESISOPROPYLATED PROPRANOLOL; PROPRANOLOL; PROPRANOLOL GLUCURONIC ACID; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; CYTOCHROME P450 1A1; WATER POLLUTANT;

ALGA; AQUATIC ENVIRONMENT; BIOACCUMULATION; BIOMARKER; DRUG; ENVIRONMENTAL EFFECT; ENVIRONMENTAL FATE; ENVIRONMENTAL RISK; EXPERIMENTAL STUDY; FOOD CHAIN; METABOLISM;

ACUTODESMUS OBLIQUUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; DAPHNIA MAGNA; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL IMPACT; ENVIRONMENTAL IMPACT ASSESSMENT; FOOD CHAIN; GOLDFISH; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TROPHIC LEVEL; ANIMAL; CARP; ENVIRONMENTAL MONITORING; LIVER; METABOLISM; TOXICITY; WATER POLLUTANT;

ALGAE; CARASSIUS; CARASSIUS AURATUS; CHLOROPHYTA; CLADOCERA; DAPHNIA; DAPHNIA MAGNA; MAMMALIA; SCENEDESMUS OBLIQUUS;

ANIMALS; CARPS; CYTOCHROME P-450 CYP1A1; ENVIRONMENTAL MONITORING; FOOD CHAIN; LIVER; MALONDIALDEHYDE; PROPRANOLOL; SUPEROXIDE DISMUTASE; WATER POLLUTANTS, CHEMICAL;

EID: 84930935945     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2015.06.002     Document Type: Article

References (71)

1. Al-Ansari A.M., Atkinson S.K., Doyle J.R., Trudeau V.L., Blais J.M. Dynamics of uptake and elimination of 17α-ethinylestradiol in male goldfish (Carassius auratus). Aquat. Toxicol. 2013, 132:134-140.
2. Alder A.C., Schaffner C., Majewsky M., Klasmeier J., Fenner K. Fate of β-blocker human pharmaceuticals in surface water: comparison of measured and simulated concentrations in the Glatt Valley Watershed, Switzerland. Water Res. 2010, 44:936-948.
3. Arnot J.A., Gobas F.A.P.C. A review of bioconcentration factor (BCF) and bioaccumulation factor (BAF) assessments for organic chemicals in aquatic organisms. Environ. Rev. 2006, 14:257-297.
4. Aruoma O.I., Smith C., Cecchini R., Evans P.J., Halliwell B. Free radical scavenging and inhibition of lipid peroxidation by β-blockers and by agents that interfere with calcium metabolism: a physiologically-significant process?. Biochem. Pharmacol. 1991, 42:735-743.
5. Bartram A.E., Winter M.J., Huggett D.B., McCormack P., Constantine L.A., Hetheridge M.J., et al. In vivo and in vitro liver and gill EROD activity in rainbow trout (Oncorhynchus mykiss) exposed to the beta-blocker propranolol. Environ. Toxicol. 2012, 27:573-582.
6. Beaudry F., Yves Le Blanc J.C., Coutu M., Ramier I., Moreau J.P., Brown N.K. Metabolite profiling study of propranolol in rat using LC/MS/MS analysis. Biomed. Chromatogr. 1999, 13:363-369.
7. Bendz D., Paxéus N.A., Ginn T.R., Loge F.J. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden. J. Hazard. Mater. 2005, 122:195-204.
8. Boonsaner M., Hawker D.W. Evaluation of food chain transfer of the antibiotic oxytetracycline and human risk assessment. Chemosphere 2013, 93:1009-1014.
9. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
10. Brodin T., Piovano S., Fick J., Klaminder J., Heynen M., Jonsson M. Ecological effects of pharmaceuticals in aquatic systems-impacts through behavioural alterations. Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci. 2014, 369(1656).
11. Caron G., Steyaert G., Pagliara A., Reymond F., Crivori P., Gaillard P., et al. Structure-lipophilicity relationships of neutral and protonated β-blockers, Part I, Intra- and intermolecular effects in isotropic solvent systems. Helv. Chim. Acta 1999, 82:1211-1222.
12. Chèvre N. Pharmaceuticals in surface waters: sources, behavior, ecological risk, and possible solutions. Case study of Lake Geneva, Switzerland. WIREs Water 2014, 1:69-86.
13. Cleuvers M. Initial risk assessment for three β-blockers found in the aquatic environment. Chemosphere 2005, 59:199-205.
14. Contardo-Jara V., Pflugmacher S., Nützmann G., Kloas W., Wiegand C. The β-receptor blocker metoprolol alters detoxification processes in the non-target organism Dreissena polymorpha. Environ. Pollut. 2010, 158:2059-2066.
15. Corcoran J., Lange A., Winter M.J., Tyler C.R. Effects of pharmaceuticals on the expression of genes involved in detoxification in a carp primary hepatocyte model. Environ. Sci. Technol. 2012, 46:6306-6314.
16. Dai Z., Xia X., Guo J., Jiang X. Bioaccumulation and uptake routes of perfluoroalkyl acids in Daphnia magna. Chemosphere 2013, 90:1589-1596.
17. Ding J., Lu G., Liang Y. Evaluation of the interactive effects of lead, zinc and benzo(k)fluoranthene on crucian carp, Carassius carassius, using a multiple biomarker approach. Bull. Environ. Contam. Toxicol. 2014, 92:534-539.
18. Du B., Haddad S.P., Luek A., Scott W.C., Saari G.N., Kristofco L.A., et al. Bioaccumulation and trophic dilution of human pharmaceuticals across trophic positions of an effluent-dependent wadeable stream. Philos. Trans. R. Soc. B 2014, 369. (20140058). 10.1098/rstb.2014.0058.
19. Du B., Haddad S.P., Scott W.C., Chambliss C.K., Brooks B.W. Pharmaceutical bioaccumulation by periphyton and snails in an effluent-dependent stream during an extreme drought. Chemosphere 2015, 119:927-934.
20. Dzialowski E.M., Turner P.K., Brooks B.W. Physiological and reproductive effects of beta adrenergic receptor antagonists in Daphnia magna. Arch. Environ. Contam. Toxicol. 2006, 50:503-510.
21. EMEA European Agency for the Evaluation of Medicinal Products. Guideline on the environmental risk assessment of medicinal products for human use 2006, (http://www.emea.europa.eu/pdfs/human/swp/444700en.pdf).
22. Ferrari B., Mons R., Vollat B., Frayse B., Paxeus N., Lo Guidice R., et al. Environmental risk assessment of six pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment?. Environ. Toxicol. Chem. 2004, 23:1344-1354.
23. Finn J., Hui M., Li V., Lorenzi V., de la Paz N., Cheng S.H., et al. Effects of propranolol on heart rate and development in Japanese medaka (Oryzias latipes) and zebrafish (Danio rerio). Aquat. Toxicol. 2012, 122:214-221.
24. Franzellitti S., Buratti S., Valbonesi P., Capuzzo A., Fabbri E. The β-blocker propranolol affects cAMP-dependent signaling and induces the stress response in Mediterranean mussels, Mytilus galloprovincialis. Aquat. Toxicol. 2011, 101:299-308.
25. Giltrow E., Eccles P.D., Winter M.J., McCormack P.J., Rand-Weaver M., Hutchinson T.H., et al. Chronic effects assessment and plasma concentrations of the β-blocker propranolol in fathead minnows (Pimephales promelas). Aquat. Toxicol. 2009, 95:195-202.
26. Gomes R.L., Deacon H.E., Lai K.M., Birkett J.W., Scrimshaw M.D., Lester J.N. An assessment of the bioaccumulation of estrone in Daphnia magna. Environ. Toxicol. Chem. 2004, 23:105-108.
27. Gomez C.F., Constantine L., Huggett D.B. The influence of gill and liver metabolism on the predicted bioconcentration of three pharmaceuticals in fish. Chemosphere 2010, 81:1189-1195.
28. Huggett D.B., Khan I.A., Foran C.M., Schlenk D. Determination of beta-adrenergic receptor blocking pharmaceuticals in United States wastewater effluent. Environ. Pollut. 2003, 121:199-205.
29. Ismail N.S., Müller C.E., Morgan R.R., Luthy R.G. Uptake of contaminants of emerging concern by the bivalves Anodonta californiensis and Corbicula fluminea. Environ. Sci. Technol. 2014, 48:9211-9219.
30. Jorgensen S.E., Halling-Sorensen B., Mahler H. Handbook of Estimation Methods in Ecotoxicology and Environmental Chemistry 1998, Lewis Publishers, Florida.
31. Kim H.Y., Jeon J., Hollender J., Yu S., Kim S.D. Aqueous and dietary bioaccumulation of antibiotic tetracycline in D. magna and its multigenerational transfer. J. Hazard. Mater. 2014, 279:428-435.
32. Kliewer S.A., Goodwin B., Willson T.M. The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr. Rev. 2002, 23:687-702.
33. Klosterhaus S.L., Grace R., Hamilton M.C., Yee D. Method validation and reconnaissance of pharmaceuticals, personal care products, and alkylphenols in surface waters, sediments, and mussels in an urban estuary. Environ. Int. 2013, 54:92-99.
34. Koelmans A.A. Limited reversibility of bioconcentration of hydrophobic organic chemicals in phytoplankton. Environ. Sci. Technol. 2014, 48:7341-7348.
35. Lahti M., Brozinski J.M., Jylhä A., Kronberg L., Oikari A. Uptake from water, biotransformation, and biliary excretion of pharmaceuticals by rainbow trout. Environ. Toxicol. Chem. 2011, 30:1403-1411.
36. Laville N., Ait-Aissa S., Gomez E., Casellas C., Porcher J.M. Effects of human pharmaceuticals on cytotoxicity, EROD activity and ROS production in fish hepatocytes. Toxicology 2004, 196:41-55.
37. Lebrun J.D., Leroy D., Giusti A., Gourlay-Francé C., Thomé J.P. Bioaccumulation of polybrominated diphenyl ethers (PBDEs) in Gammarus pulex: relative importance of different exposure routes and multipathway modeling. Aquat. Toxicol. 2014, 154:107-113.
38. Liu J., Lu G., Zhang Z., Bao Y., Liu F., Wu D., et al. Biological effects and bioaccumulation of pharmaceutically active compounds in crucian carp caged near the outfall of a sewage treatment plant. Environ. Sci. Process. Impacts 2015, 10.1039/c4em00472h.
39. Liu J., Lu G., Xie Z., Zhang Z., Li S., Yan Z. Occurrence, bioaccumulation and risk assessment of lipophilic pharmaceutically active compounds in the downstream rivers of sewage treatment plants. Sci. Total Environ. 2015, 511:54-62.
40. Lorenzi V., Mehinto A.C., Denslow N.D., Schlenk D. Effects of exposure to the β-blocker propranolol on the reproductive behavior and gene expression of the fathead minnow, Pimephales promelas. Aquat. Toxicol. 2012, 116:8-15.
41. Lu G.H., Yuan X., Zhao Y.H. QSAR study on the toxicity of substituted benzenes to the algae (Scenedesmus obliquus). Chemosphere 2001, 44:437-440.
42. Luo Y., Sui Y., Wang X., Tian Y. 2-Chlorophenol induced hydroxyl radical production in mitochondria in Carassius auratus and oxidative stress-an electron paramagnetic resonance study. Chemosphere 2008, 71:1260-1268.
43. Madenjian C.P., Hesselberg R.J., DeSorcie T.J., Schmidt L.J., Stedman R.M., Quintal R.T., et al. Estimate of net trophic transfer efficiency of PCBs to Lake Michigan lake trout from their prey. Environ. Sci. Technol. 1998, 32:886-891.
44. Magnusson K., Tiselius P. The importance of uptake from food for the bioaccumulation of PCB and PBDE in the marine planktonic copepod Acartia clausi. Aquat. Toxicol. 2010, 98:374-380.
45. Marklund S., Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 1974, 47:469-474.
46. Massarsky A., Trudeau V.L., Moon T.W. β-blockers as endocrine disruptors: the potential effects of human β-blockers on aquatic organisms. J. Exp. Zool. A Ecol. Genet. Physiol. 2011, 315:251-265.
47. Masubuchi Y., Hosokawa S., Horie T., Suzuki T., Ohmori S., Kitada M., et al. Cytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase. Drug Metab. Dispos. 1994, 22:909-915.
48. Maszkowska J., Stolte S., Kumirska J., Łukaszewicz P., Mioduszewska K., Puckowski A., et al. Beta-blockers in the environment: Part I. Mobility and hydrolysis study. Sci. Total Environ. 2014, 493:1112-1121.
49. Maszkowska J., Stolte S., Kumirska J., Łukaszewicz P., Mioduszewska K., Puckowski A., et al. Beta-blockers in the environment: Part II. Ecotoxicity study. Sci. Total Environ. 2014, 493:1122-1126.
50. Maurer M., Escher B.I., Richle P., Schaffner C., Alder A.C. Elimination of β-blockers in sewage treatment plants. Water Res. 2007, 41:1614-1622.
51. Mayeaux M.H., Winston G.W. Antibiotic effects on cytochromes P450 content and mixed-function oxygenase (MFO) activities in the American alligator, Alligator mississippiensis. J. Vet. Pharmacol. Ther. 1998, 21:274-281.
52. Meredith-Williams M., Carter L.J., Fussell R., Raffaelli D., Ashauer R., Boxall A. Uptake and depuration of pharmaceuticals in aquatic invertebrates. Environ. Pollut. 2012, 165:250-258.
53. Narimatsu S., Mochida M., Ueno K., Horie T., Yamamoto S., Suzuki T. Induction of cytochrome P450 1A1 in mice by repeated oral administration of propranolol. Drug Metab. Pharmacokinet. 2002, 17:54-59.
54. OECD Organization for Economic Co-operation and Development. Guidelines for the testing of chemicals 2008.
55. Orias F., Simon L., Perrodin Y. Experimental assessment of the bioconcentration of 15N-tamoxifen in Pseudokirchneriella subcapitata. Chemosphere 2015, 122:251-256.
56. Owen S.F., Giltrow E., Huggett D.B., Hutchinson T.H., Saye J., Winter M.J., et al. Comparative physiology, pharmacology and toxicology of β-blockers: mammals versus fish. Aquat. Toxicol. 2007, 82:145-162.
57. Owen S.F., Huggett D.B., Hutchinson T.H., Hetheridge M.J., Kinter L.B., Ericson J.F., et al. Uptake of propranolol, a cardiovascular pharmaceutical, from water into fish plasma and its effects on growth and organ biometry. Aquat. Toxicol. 2009, 93:217-224.
58. Randall D.J., Connell D.W., Yang R., Wu S.S. Concentrations of persistent lipophilic compounds in fish are determined by exchange across the gills, not through the food chain. Chemosphere 1998, 37:1263-1270.
59. Rendal C., Kusk K.O., Trapp S. Optimal choice of pH for toxicity and bioaccumulation studies of ionizing organic chemicals. Environ. Toxicol. Chem. 2011, 30:2395-2406.
60. Solé M., Shaw J.P., Frickers P.E., Readman J.W., Hutchinson T.H. Effects of feeding rate and biomarker responses of marine mussels experimentally exposed to propranolol and acetaminophen. Anal. Bioanal. Chem. 2010, 396:649-656.
61. Sprouse J.S., Aghajanian G.K. (-)-Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists. Eur. J. Pharmacol. 1986, 128:295-298.
62. Sugawara H., Tobise K., Onodera S. Absence of antioxidant effects of nifedipine and diltiazem on myocardial membrane lipid peroxidation in contrast with those of nisoldipine and propranolol. Biochem. Pharmacol. 1994, 47:887-892.
63. Uno T., Ishizuka M., Itakura T. Cytochrome P450 (CYP) in fish. Environ. Toxicol. Pharmacol. 2012, 34:1-13.
64. US EPA Method 1694: Pharmaceuticals and Personal Care Products in Water, Soil, Sediment and Biosolids 2007, 1-77. HPLC/MS/MS, Washington, DC, (EPA-821-R-08-002).
65. Vernouillet G., Eullaffroy P., Lajeunesse A., Blaise C., Gagné F., Juneau P. Toxic effects and bioaccumulation of carbamazepine evaluated by biomarkers measured in organisms of different trophic levels. Chemosphere 2010, 80:1062-1068.
66. Wassmur B., Gräns J., Kling P., Celander M.C. Interactions of pharmaceuticals and other xenobiotics on hepatic pregnane X receptor and cytochrome P450 3A signaling pathway in rainbow trout (Oncorhynchus mykiss). Aquat. Toxicol. 2010, 100:91-100.
67. Wu X., Noda A., Noda H., Imamura Y. Side-chain metabolism of propranolol: involvement of monoamine oxidase and aldehyde reductase in the metabolism of N-desisopropylpropranolol to propranolol glycol in rat liver. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2001, 129:361-368.
68. Yoshimoto K., Echizen H., Chiba K., Tani M., Ishizaki T. Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers-N-desisopropylation is mediated mainly by CYP1A2. Br. J. Clin. Pharmacol. 1995, 39:421-431.
69. Yu M., Luo X.J., Wu J.P., Chen S.J., Mai B.X. Bioaccumulation and trophic transfer of polybrominated diphenyl ethers (PBDEs) in biota from the Pearl River Estuary, South China. Environ. Int. 2009, 35:1090-1095.
70. Yu Y., Huang Q., Wang Z., Zhang K., Tang C., Cui J., et al. Occurrence and behavior of pharmaceuticals, steroid hormones, and endocrine-disrupting personal care products in wastewater and the recipient river water of the Pearl River Delta, South China. J. Environ. Monit. 2011, 13:871-878.
71. Zenker A., Cicero M.R., Prestinaci F., Bottoni P., Carere M. Bioaccumulation and biomagnification potential of pharmaceuticals with a focus to the aquatic environment. J. Environ. Manag. 2014, 133:378-387.